| Sinovac Wins Order for China’s National Immunization Program ChinaBio Today submits: Sinovac Biotech (NSDQ: SVA) was selected to supply its hepatitis A vaccine, Healive®, to the Beijing Expanded Program of Immunization [EPI]. Sinovac was selected one of the two suppliers and was allocated a greater share of the total purchase order. The decision was made by the Beijing CDC, which evaluated suppliers on the basis of several criteria, including product quality, service and price. The order was for 477,000 doses. As a point of reference, Healive orders for the third quarter of 2009 were almost 1 million.Complete Story » seekingalpha.com |
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2010 Financial Results Conference Call (PR Newswire) In conjunction with its second quarter 2010 earnings release , Covance Inc. is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, July 29, 2010 at 9:00 a.m. us.rd.yahoo.com |
New Challenge for Baxter in Heparin Suit Baxter faces a new challenge in federal court in its bid to block disclosure of documents about the 2008 contaminated-heparin crisis. online.wsj.com |
Council Sets Abortion Fight The City Council plans to unveil legislation Tuesday that would establish strict disclosure requirements for crisis-pregnancy centers, some of which, abortion-rights advocates charge, deceive women. online.wsj.com |
FDA Extends Review of Merck Drug The U.S. Food and Drug Administration extended its review of German drug maker Merck's potential blockbuster Cladribine, feeding hope the treatment could be approved despite a negative opinion from European authorities. online.wsj.com |